Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Costa Rica

Costa Ricans Claim Improper 'Big Pharma' Links

July 2006 | Legal News

Costa Rican lawmakers have criticised what they allege is undue influence on the country's health minister, María Luisa Ávila, from large pharmaceutical companies. According to a report, Ávila participated in a clinical trial carried out by France's Sanofi-Aventis in 2005 while working for national health service CCSS. The claims also refer to alleged relationships with a number of other, US-based, drug multinationals conducting tests in Costa Rica from 2000 onwards.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
South Korea Attracted By Bioprospects

Companies / Costa Rica The South Korean government has become the latest party to display an interest in Costa Rica's abundant biodiversity by entering into a partnership with the National Biodiversity Institute of Costa Rica...
February 2008
Narrow Victory For Free Trade

Industry / Costa Rica The Costa Rican electorate have given a shaky thumbs-up to the Central American and Dominican Republic Free Trade Agreement (CAFTA-DR) with 51.6% voting 'yes' in a national referendum. The vote will...
October 2007
Central American Markets Growing

Companies / Costa Rica According to IMS data, Panama's pharmaceutical market expanded by 5.2% in 2005, with Costa Rica growing 11%. According to BMI estimates, the two markets were respectively worth US$190mn and US$250mn...
July 2006
PhRMA Blasts Western Hemisphere Market Access Barriers

Companies US R&D-based industry association PhRMA has condemned market access barriers - including intellectual property violations, price controls and red tape - in Canada and Latin America. The influential...
April 2006
Costa Rica Introduces Generic Equivalence Rules

Companies / Costa Rica Costa Rica's health ministry has introduced new rules obliging drugmakers to prove therapeutic equivalence for generic products in regulatory submissions. The regulations became effective on February...
February 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS